XON Stock Price, News & Analysis

XON NASDAQ

Company Description

XON (NASDAQ: XON) is a publicly traded biotechnology company in the Health Technology sector.

XON stock has declined 39.3% over the past year.

This page provides a comprehensive overview of XON stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-39.3%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

XON (XON) stock. Over the past 12 months, the stock has lost 39.3%.

Latest News

View All

April 28, 2022

—

Biotech Company Allonnia Appoints Lieutenant General (Ret.) Thomas P. Bostick to Board of Directors; Celebrates Additions to Advisory Team

management

January 26, 2021

—

Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

offering

January 6, 2021

—

Precigen to Present at the 39th Annual J.P. Morgan Healthcare Conference

conferences

November 9, 2020

—

Precigen Reports Third Quarter 2020 and Year-to-Date Financial Results

earnings

November 2, 2020

—

Precigen to Announce Third Quarter 2020 Financial Results on November 9th: Will host Pipeline and Data Update Call in Early December

earnings

XON has 5 recent news articles. Key topics include management, offering, conferences, earnings. View all XON news →

SEC Filings

View All

No SEC filings available for XON.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

XON Company Profile & Sector Positioning

XON (XON) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NASDAQ.